|
Volumn 21, Issue 5, 2010, Pages 881-885
|
Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ARTICLE;
BLADDER TUMOR;
CANCER INVASION;
CANCER STAGING;
CARCINOMA;
CYSTECTOMY;
DISEASE COURSE;
FEMALE;
HUMAN;
INDIA;
INTRAVESICAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
PATHOLOGY;
PATIENT SELECTION;
QUALITY OF LIFE;
REOPERATION;
RETROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
URINARY DIVERSION;
UROLOGIC SURGERY;
ADMINISTRATION, INTRAVESICAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA;
CHEMOTHERAPY, ADJUVANT;
CYSTECTOMY;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
INDIA;
MALE;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PATIENT SELECTION;
QUALITY OF LIFE;
RADIOTHERAPY, ADJUVANT;
REOPERATION;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
URINARY RESERVOIRS, CONTINENT;
UROLOGIC SURGICAL PROCEDURES;
|
EID: 79952062177
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|